Patent Number | Grant Date | Title | Total Oppositions |
---|---|---|---|
EP2919766 | May 26, 2021 | Sustained-Release Dosage Forms Of Ruxolitinib | 4 |
EP3070090 | Dec 12, 2018 | Use Of Salts Of The Janus Kinase Inhibitor (R)-3-(4-(7H-Pyrrolo[2,3-D]Pyrimidin-4-Yl)-1H- Pyrazol-1-Yl)-3- Cyclopentylpropanenitrile | 1 |
EP3184526 | Oct 3, 2018 | Pyrrolo[2,3-D]Pyrimidine Derivatives As Janus Kinase Inhibitor | 1 |
EP2671882 | Feb 21, 2018 | Pyrrolo[2,3-B]Pyridin-4-Yl-Amines And Pyrrolo[2M3-B]Pyrimidin-4-Yl-Amines As Janus Kinase Inhibitors | 1 |
EP3050882 | Jan 31, 2018 | Piperidin-4-Yl Azetidine Derivatives As Jak1 Inhibitors | 1 |
EP2300455 | Jul 19, 2017 | Salts Of 2-Fluoro-N-Methyl-4-[7-(Quinolin-6-Yl-Methyl) - Imidazo [1, 2-B] [1, 2, 4] Triazin-2-Yl] Benzamide And Processes Related To Preparing The Same | 1 |
Feel free to send us a message here and we will get back to you